Functional status and quality of life in chronic obstructive pulmonary disease

被引:145
作者
Reardon, Jane Z.
Lareau, Suzanne C.
ZuWallack, Richard
机构
[1] Hartford Hosp, Hartford, CT 06115 USA
[2] New Mexico Vet Affairs Healthcare Syst, Dept Internal Med, Pulm Sect, Albuquerque, NM USA
[3] Univ Connecticut, Sch Med, Dept Med, Farmington, CT USA
[4] St Francis Hosp & Med Ctr, Div Pulm & Crit Care, Hartford, CT 06105 USA
关键词
activities of daily living; chronic obstructive pulmonary disease; functional status; quality of life;
D O I
10.1016/j.amjmed.2006.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exertional dyspnea often causes patients with chronic obstructive pulmonary disease (COPD) to unconsciously reduce their activities of daily living (ADLs) to reduce the intensity of their distress. The reduction in ADLs leads to deconditioning which, in turn, further increases dyspnea. Both dyspnea and fatigue are important factors affecting health-related quality of life (HRQOL). The functional status of patients relates to how well they perform ADLs. Activities, however, may not be severely limited until the disease becomes advanced. The elimination of an ADL depends on the necessity or desirability of that activity and the intensity of the associated symptoms. HRQOL is measured using symptoms, functional status, and a rating of their impact on the individual. The Pulmonary Functional Status Scale (PFSS) and the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ) are 2 COPD-specific functional status questionnaires. Pedometers or accelerometers can quantify the levels of activity of patients with COPD. HRQOL is measured with validated multidimensional questionnaires that cover symptoms, physical, psychological, and social domains. Ideally, these instruments are discriminative (i.e., separate degrees of impairment) and evaluative (i.e., detect small changes after therapy). HRQOL questionnaires may be generic (e. g., Medical Outcomes Study Short Form-36 [SF-36]) and can measure favorable changes after intervention, such as pulmonary rehabilitation, or they can be disease specific with disease-related domains, e. g., Chronic Respiratory Disease Questionnaire (CRQ) with domains of dyspnea, fatigue, emotion, and mastery; and St. George's Respiratory Questionnaire (SGRQ) with domains of symptoms, activity, and psychosocial impact. A case is presented that depicts how these tools may be used to evaluate improvement with intervention in a patient with COPD. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:S32 / S37
页数:6
相关论文
共 27 条
[1]   Accuracy of five electronic pedometers for measuring distance walked [J].
Bassett, DR ;
Ainsworth, BE ;
Leggett, SR ;
Mathien, CA ;
Main, JA ;
Hunter, DC ;
Duncan, GE .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1996, 28 (08) :1071-1077
[2]   Functional status and survival following pulmonary rehabilitation [J].
Bowen, JB ;
Votto, JJ ;
Thrall, RS ;
Haggerty, MC ;
Stockdale-Woolley, R ;
Bandyopadhyay, T ;
ZuWallack, RL .
CHEST, 2000, 118 (03) :697-703
[3]   Measuring quality of life - Is quality of life determined by expectations or experience? [J].
Carr, AJ ;
Gibson, B ;
Robinson, PG .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7296) :1240-1243
[4]   Patient-assessed health outcomes in chronic lung disease - What are they, how do they help us, and where do we go from here? [J].
Curtis, JR ;
Martin, DP ;
Martin, TR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (04) :1032-1039
[5]   Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD [J].
de Torres, JP ;
Pinto-Plata, V ;
Ingenito, E ;
Bagley, P ;
Gray, A ;
Berger, R ;
Celli, B .
CHEST, 2002, 121 (04) :1092-1098
[6]  
GARCIAAYMERICH J, 2006, THORAX 0531
[7]   Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation [J].
Guyatt, GH ;
King, DR ;
Feeny, DH ;
Stubbing, D ;
Goldstein, RS .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (03) :187-192
[8]   A MEASURE OF QUALITY-OF-LIFE FOR CLINICAL-TRIALS IN CHRONIC LUNG-DISEASE [J].
GUYATT, GH ;
BERMAN, LB ;
TOWNSEND, M ;
PUGSLEY, SO ;
CHAMBERS, LW .
THORAX, 1987, 42 (10) :773-778
[9]  
Haggerty M C, 1999, J Cardiopulm Rehabil, V19, P35, DOI 10.1097/00008483-199901000-00005
[10]   MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE [J].
JAESCHKE, R ;
SINGER, J ;
GUYATT, GH .
CONTROLLED CLINICAL TRIALS, 1989, 10 (04) :407-415